At Zelira Therapeutics we have been committed to research from the beginning and remain dedicated to building evidence for our products through clinical trials and ongoing real-world data collection in collaboration with specialists around the world.

These studies, both completed and ongoing, continue to build the evidence base for our products and inform the design of future clinical trials. We are committed to providing doctors and patients with the data and information they would expect from any pharmaceutical product. In this way we are accelerating our products along the pathway to regulatory approval and reducing the risks and costs of our clinical development program.